La Verde N - Search Results

1

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy.

Zambelli A, Cazzaniga M, La Verde N, Munzone E, Antonazzo IC, Mantovani LG, Di Cosimo S, Mancuso A, Generali D, Cortesi PA. Zambelli A, et al. Among authors: la verde n. Breast. 2023 Oct;71:113-121. doi: 10.1016/j.breast.2023.08.005. Epub 2023 Aug 8. Breast. 2023. PMID: 37573652 Free PMC article.

2

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

Santini D, Barni S, Intagliata S, Falcone A, Ferraù F, Galetta D, Moscetti L, La Verde N, Ibrahim T, Petrelli F, Vasile E, Ginocchi L, Ottaviani D, Longo F, Ortega C, Russo A, Badalamenti G, Collovà E, Lanzetta G, Mansueto G, Adamo V, De Marinis F, Satolli MA, Cantile F, Mancuso A, Tanca FM, Addeo R, Russano M, Sterpi M, Pantano F, Vincenzi B, Tonini G. Santini D, et al. Among authors: la verde n. Sci Rep. 2015 Dec 22;5:18670. doi: 10.1038/srep18670. Sci Rep. 2015. PMID: 26690845 Free PMC article.

3

Development and clinical indications of cetuximab.

Labianca R, La Verde N, Garassino MC. Labianca R, et al. Among authors: la verde n. Int J Biol Markers. 2007 S4 - Jan-Mar;22(4):40-46. doi: 10.1177/17246008070221s405. Int J Biol Markers. 2007. PMID: 28207113 Free article.

4

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

Santini D, Barni S, Intagliata S, Falcone A, Ferraù F, Galetta D, Moscetti L, La Verde N, Ibrahim T, Petrelli F, Vasile E, Ginocchi L, Ottaviani D, Longo F, Ortega C, Russo A, Badalamenti G, Collovà E, Lanzetta G, Mansueto G, Adamo V, De Marinis F, Satolli MA, Cantile F, Mancuso A, Tanca FM, Addeo R, Russano M, Sterpi M, Pantano F, Vincenzi B, Tonini G. Santini D, et al. Among authors: la verde n. Sci Rep. 2016 Apr 15;6:22205. doi: 10.1038/srep22205. Sci Rep. 2016. PMID: 27079142 Free PMC article. No abstract available.

5

Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.

Garassino MC, Borgonovo K, Rossi A, Mancuso A, Martelli O, Tinazzi A, Di Cosimo S, La Verde N, Sburlati P, Bianchi C, Farina G, Torri V. Garassino MC, et al. Among authors: la verde n. Anticancer Res. 2009 Jul;29(7):2691-701. Anticancer Res. 2009. PMID: 19596948 Free article. Review.

6

Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy.

Gullo G, Bettio D, Zuradelli M, Masci G, Giordano L, Bareggi C, Tomirotti M, Salvini P, Runza L, La Verde N, Santoro A. Gullo G, et al. Among authors: la verde n. Breast. 2013 Apr;22(2):190-193. doi: 10.1016/j.breast.2013.01.005. Epub 2013 Mar 7. Breast. 2013. PMID: 23473771 Free article.

7

Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers.

La Verde N, Collovà E, Lonardi S, Generali D, Moretti A, Atzori F, Cazzaniga M, Saggia C, Tondulli L, Marcon I, Gentile AL, Rossello R, Martelli O, Aglione S, Farina G, Cinquini M, Garassino M. La Verde N, et al. Tumori. 2013 Sep-Oct;99(5):596-600. doi: 10.1177/030089161309900506. Tumori. 2013. PMID: 24362863

8

Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis.

Collovà E, Ferzi A, Scandurra G, Aurilio G, Torri V, Porcu L, Sanò MV, Taibi E, Foglietta J, Generali D, Andreis D, Dazzani MC, Bramati A, Marcon I, Atzori F, Cinieri S, Tondulli L, Grasso D, Nolè F, Petrella MC, Gori S, La Verde N. Collovà E, et al. Among authors: la verde n. Tumori. 2014 Jul-Aug;100(4):426-31. doi: 10.1700/1636.17902. Tumori. 2014. PMID: 25296592

9

Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.

Fabi A, Moscetti L, Ciccarese M, Caramanti M, Salesi N, La Verde N, Russillo M, Generali D, Scandurra G, Vari S, Pacetti U, Cognetti F, Giannarelli D. Fabi A, et al. Among authors: la verde n. Future Oncol. 2015;11(3):431-8. doi: 10.2217/fon.14.271. Future Oncol. 2015. PMID: 25675124

10

Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study.

La Verde N, Biagioli E, Gerardi C, Cordovana A, Casiraghi C, Floriani I, Bernardin E, Farina G, Di Cosimo S, Dazzani MC, Gherardi G. La Verde N, et al. Springerplus. 2016 Feb 3;5:114. doi: 10.1186/s40064-016-1720-9. eCollection 2016. Springerplus. 2016. PMID: 26885467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page